Nusano Raises $41M in Seed Round 

Nusano (previously known as Alpha Source Inc./Alpha Isotopes) filed paperwork with the United States Securities and Exchange Commission on October 24, 2018 detailing a $41 million seed funding round from investors. 

With its patented technology, Nusano is working to transform the production of medical-grade radioisotopes to enable advancements in cancer treatment and health care.  

Read more in the Los Angeles Business Journal 

Learn more

Related articles


Sign up to receive company news and updates